Clinical trial
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in…
NCT00184613 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184613 |
|---|---|
| Title | Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes |
| Official title | An Open-label, Randomised, In-patient, Cross Over PK/PD Trial Investigating the Pharmackinectic and Pharmacodynamic Profiles Following Continuous Subcutaneous Infusion of Insulin Aspart or Injection of Insulin Glargine in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2, Delivery Systems |
| Intervention type | Device, Drug |
| Interventions | pump, insulin glargine, insulin aspart |
| Enrollment | 22 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 17, 2016 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: